404 related articles for article (PubMed ID: 27826971)
1. Predictors of blood pressure control in patients with resistant hypertension.
Pales J; Kamensky G; Payer J
Bratisl Lek Listy; 2016; 117(10):571-576. PubMed ID: 27826971
[TBL] [Abstract][Full Text] [Related]
2. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).
Naser N; Dzubur A; Durak A; Kulic M; Naser N
Med Arch; 2016 Jul; 70(4):274-279. PubMed ID: 27703288
[TBL] [Abstract][Full Text] [Related]
3. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
Mazza A; Lenti S; Schiavon L; Sacco AP; Dell'Avvocata F; Rigatelli G; Ramazzina E
Adv Ther; 2017 Apr; 34(4):975-985. PubMed ID: 28299716
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
[TBL] [Abstract][Full Text] [Related]
5. Magnitude of Hypotension Based on Office and Ambulatory Blood Pressure Monitoring: Results From a Cohort of 5066 Treated Hypertensive Patients Aged 80 Years and Older.
Divisón-Garrote JA; Ruilope LM; de la Sierra A; de la Cruz JJ; Vinyoles E; Gorostidi M; Escobar-Cervantes C; Velilla-Zancada SM; Segura J; Banegas JR
J Am Med Dir Assoc; 2017 May; 18(5):452.e1-452.e6. PubMed ID: 28246017
[TBL] [Abstract][Full Text] [Related]
6. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
Mathiassen ON; Vase H; Bech JN; Christensen KL; Buus NH; Schroeder AP; Lederballe O; Rickers H; Kampmann U; Poulsen PL; Hansen KW; Btker HE; Peters CD; Engholm M; Bertelsen JB; Lassen JF; Langfeldt S; Andersen G; Pedersen EB; Kaltoft A
J Hypertens; 2016 Aug; 34(8):1639-47. PubMed ID: 27228432
[TBL] [Abstract][Full Text] [Related]
7. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
8. ABPM vs office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients.
Ferraris JR; Ghezzi L; Waisman G; Krmar RT
Pediatr Transplant; 2007 Feb; 11(1):24-30. PubMed ID: 17239120
[TBL] [Abstract][Full Text] [Related]
9. Relationship between ambulatory blood pressure monitoring values and future occurrence of ischemic cerebrovascular and coronary events in hypertensive patients.
Bastos JM; Bertoquini S; Silva JA; Polónia J
Rev Port Cardiol; 2006 Mar; 25(3):305-16. PubMed ID: 16789404
[TBL] [Abstract][Full Text] [Related]
10. Renal denervation in moderate treatment-resistant hypertension.
Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
[TBL] [Abstract][Full Text] [Related]
11. Hypotension based on office and ambulatory monitoring blood pressure. Prevalence and clinical profile among a cohort of 70,997 treated hypertensives.
Divisón-Garrote JA; Banegas JR; De la Cruz JJ; Escobar-Cervantes C; De la Sierra A; Gorostidi M; Vinyoles E; Abellán-Aleman J; Segura J; Ruilope LM
J Am Soc Hypertens; 2016 Sep; 10(9):714-23. PubMed ID: 27451950
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension.
Muxfeldt ES; Bloch KV; Nogueira AR; Salles GF
Blood Press Monit; 2003 Oct; 8(5):181-5. PubMed ID: 14624166
[TBL] [Abstract][Full Text] [Related]
13. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
Hermida RC; Ayala DE; Fernández JR; Mojón A
Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy.
Csiky B; Kovács T; Wágner L; Vass T; Nagy J
Nephrol Dial Transplant; 1999 Jan; 14(1):86-90. PubMed ID: 10052483
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.
White WB; Weber MA; Davidai G; Neutel JM; Bakris GL; Giles T
Blood Press Monit; 2005 Jun; 10(3):157-63. PubMed ID: 15923818
[TBL] [Abstract][Full Text] [Related]
17. Management of patients with uncontrolled arterial hypertension--the role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCTZ.
Mengden T; Vetter H; Tousset E; Uen S
BMC Cardiovasc Disord; 2006 Aug; 6():36. PubMed ID: 16942618
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
Punzi HA
Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
[TBL] [Abstract][Full Text] [Related]
19. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
Kreutz R; Scholze J; Douros A
Curr Vasc Pharmacol; 2018 Jan; 16(2):197-203. PubMed ID: 28828980
[TBL] [Abstract][Full Text] [Related]
20. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
